FN1 and diabetic kidney disease: We found, unexpectedly, that glucosamine reduced mesangial expansion and expression of fibronectin and α-SMA in diabetic nephropathy, and decreased the number of α-SMA+ endothelial cells in the glomeruli, while renal function and expression of inflammatory factors and other genes associated with accumulation of extracellular matrix were not affected by glucosamine.